234 related articles for article (PubMed ID: 31494062)
21. Incidence of venous thromboembolism in patients with non-Hodgkin lymphoma.
Sanfilippo KM; Wang TF; Gage BF; Luo S; Riedell P; Carson KR
Thromb Res; 2016 Jul; 143():86-90. PubMed ID: 27208462
[TBL] [Abstract][Full Text] [Related]
22. Primary renal lymphoma: A population-based analysis using the SEER program (1973-2015).
Taneja A; Kumar V; Chandra AB
Eur J Haematol; 2020 May; 104(5):390-399. PubMed ID: 31769538
[TBL] [Abstract][Full Text] [Related]
23. Non-Hodgkin Lymphoma in the Middle East Is Characterized by Low Incidence Rates With Advancing Age.
Yaqo RT; Jalal SD; Ghafour KJ; Hassan HA; Hughson MD
J Glob Oncol; 2019 Apr; 5():1-10. PubMed ID: 30978153
[TBL] [Abstract][Full Text] [Related]
24. Primary testicular diffuse large B-cell lymphoma: a population-based study on the incidence, natural history, and survival comparison with primary nodal counterpart before and after the introduction of rituximab.
Gundrum JD; Mathiason MA; Moore DB; Go RS
J Clin Oncol; 2009 Nov; 27(31):5227-32. PubMed ID: 19770371
[TBL] [Abstract][Full Text] [Related]
25. Persistent socioeconomic inequalities in cancer survival in the United States: 1973-2007 surveillance, epidemiology and end results (SEER) data for breast cancer and non-Hodgkin's lymphoma.
Kato I; Booza J; Quarshie WO; Schwartz K
J Registry Manag; 2012; 39(4):158-66. PubMed ID: 23493021
[TBL] [Abstract][Full Text] [Related]
26. Lymphoma in adolescents and young adults.
Jaglowski SM; Linden E; Termuhlen AM; Flynn JM
Semin Oncol; 2009 Oct; 36(5):381-418. PubMed ID: 19835736
[TBL] [Abstract][Full Text] [Related]
27. The epidemic of non-Hodgkin lymphoma in the United States: disentangling the effect of HIV, 1992-2009.
Shiels MS; Engels EA; Linet MS; Clarke CA; Li J; Hall HI; Hartge P; Morton LM
Cancer Epidemiol Biomarkers Prev; 2013 Jun; 22(6):1069-78. PubMed ID: 23595542
[TBL] [Abstract][Full Text] [Related]
28. Adolescent weight and height are predictors of specific non-Hodgkin lymphoma subtypes among a cohort of 2,352,988 individuals aged 16 to 19 years.
Leiba M; Leiba A; Keinan-Boker L; Avigdor A; Derazne E; Levine H; Kark JD
Cancer; 2016 Apr; 122(7):1068-77. PubMed ID: 26900677
[TBL] [Abstract][Full Text] [Related]
29. Conjunctival Lymphoma--An International Multicenter Retrospective Study.
Kirkegaard MM; Rasmussen PK; Coupland SE; Esmaeli B; Finger PT; Graue GF; Grossniklaus HE; Honavar SG; Khong JJ; McKelvie PA; Mulay K; Prause JU; Ralfkiaer E; Sjö LD; Toft PB; Vemuganti GK; Thuro BA; Curtin J; Heegaard S
JAMA Ophthalmol; 2016 Apr; 134(4):406-14. PubMed ID: 26891973
[TBL] [Abstract][Full Text] [Related]
30. Cause-specific mortality among Medicare beneficiaries with newly diagnosed non-Hodgkin lymphoma subtypes.
Hester LL; Park SI; Wood WA; Stürmer T; Brookhart MA; Lund JL
Cancer; 2019 Apr; 125(7):1101-1112. PubMed ID: 30548238
[TBL] [Abstract][Full Text] [Related]
31. Non-Hodgkin's lymphoma: an analysis of the Metropolitan Detroit SEER database.
Varterasian ML; Graff JJ; Severson RK; Weiss L; al-Katib AM; Kalemkerian GP
Cancer Invest; 2000; 18(4):303-8. PubMed ID: 10808365
[TBL] [Abstract][Full Text] [Related]
32. Primary renal lymphoma: a population-based study in the United States, 1980-2013.
Chen J; Peng J; Zheng Y; Li S; Yang P; Wu X; Tian H; Liu H; Yang S; Wang W; Wu B
Sci Rep; 2019 Oct; 9(1):15125. PubMed ID: 31641184
[TBL] [Abstract][Full Text] [Related]
33. Comprehensive Evaluation of Medical Conditions Associated with Risk of Non-Hodgkin Lymphoma using Medicare Claims ("MedWAS").
Engels EA; Parsons R; Besson C; Morton LM; Enewold L; Ricker W; Yanik EL; Arem H; Austin AA; Pfeiffer RM
Cancer Epidemiol Biomarkers Prev; 2016 Jul; 25(7):1105-13. PubMed ID: 27197296
[TBL] [Abstract][Full Text] [Related]
34. Risk and subtypes of secondary primary malignancies in diffuse large B-cell lymphoma survivors change over time based on stage at diagnosis.
Major A; Smith DE; Ghosh D; Rabinovitch R; Kamdar M
Cancer; 2020 Jan; 126(1):189-201. PubMed ID: 31509235
[TBL] [Abstract][Full Text] [Related]
35. Sites of extranodal involvement are prognostic in patients with diffuse large B-cell lymphoma in the rituximab era: an analysis of the Surveillance, Epidemiology and End Results database.
Castillo JJ; Winer ES; Olszewski AJ
Am J Hematol; 2014 Mar; 89(3):310-4. PubMed ID: 24273125
[TBL] [Abstract][Full Text] [Related]
36. Race/ethnicity-specific disparities in cancer incidence, burden of disease, and overall survival among patients with hepatocellular carcinoma in the United States.
Ha J; Yan M; Aguilar M; Bhuket T; Tana MM; Liu B; Gish RG; Wong RJ
Cancer; 2016 Aug; 122(16):2512-23. PubMed ID: 27195481
[TBL] [Abstract][Full Text] [Related]
37. Changing incidence of non-Hodgkin lymphomas in the United States.
Clarke CA; Glaser SL
Cancer; 2002 Apr; 94(7):2015-23. PubMed ID: 11932904
[TBL] [Abstract][Full Text] [Related]
38. Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001.
Morton LM; Wang SS; Devesa SS; Hartge P; Weisenburger DD; Linet MS
Blood; 2006 Jan; 107(1):265-76. PubMed ID: 16150940
[TBL] [Abstract][Full Text] [Related]
39. Risk for malignancies of infectious etiology among adult survivors of specific non-Hodgkin lymphoma subtypes.
Herr MM; Schonfeld SJ; Dores GM; Engels EA; Tucker MA; Curtis RE; Morton LM
Blood Adv; 2019 Jul; 3(13):1961-1969. PubMed ID: 31262739
[TBL] [Abstract][Full Text] [Related]
40. Intravascular large B-cell lymphoma in the United States (US): a population-based study using Surveillance, Epidemiology, and End Results program and National Cancer Database.
Rajyaguru DJ; Bhaskar C; Borgert AJ; Smith A; Parsons B
Leuk Lymphoma; 2017 Sep; 58(9):1-9. PubMed ID: 28278725
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
